Pfizer Inc reported a 32% fall in second-quarter profit on Tuesday due to a dip in demand for some of its drugs from the COVID-19 pandemic and from rising competition, as the company and partner began a global study into a vaccine candidate to fight the health crisis.
FILE PHOTO: A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri/File Photo
- Pfizer Inc reported a 32% fall in second-quarter profit on Tuesday due to a dip in demand for some of its drugs from the COVID-19 pandemic and from rising competition, as the company and partner began a global study into a vaccine candidate to fight the health crisis. The U.S. drugmaker said net income fell to $3.43 billion, or 61 cents per share, in the quarter, from $5.05 billion, or 89 cents per share, a year earlier.Pfizer and German biotech BioNTech drugmaker said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer-BioNTech begin late-stage study of lead COVID-19 vaccine candidateGerman biotech BioNTech and U.S. drugmaker Pfizer Inc said on Monday they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
Read more »
Pfizer Sales Fall as Company Races Toward Covid-19 VaccinePfizer reported growth in its biopharma division in the latest quarter, but overall sales fell amid increased competition in its generic-drug business.
Read more »
Stocks making the biggest moves after hours: Pfizer, F5 Networks, Virgin Galactic and moreSee which stocks are posting big moves after the bell.
Read more »
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
Read more »
Moderna, Pfizer Coronavirus Vaccines Begin Final-Stage TestingTwo of the most advanced experimental vaccines entered the pivotal phase of their studies, with the first subjects receiving doses of Moderna vaccine and Pfizer preparing to inject participants in its trial.
Read more »
Futures slip with focus on stimulus talks, Pfizer, McDonald's earningsU.S. stock index futures retreated on Tuesday as lawmakers geared up to debate a coronavirus relief deal to limit the economic damage from the pandemic, with investors also keeping an eye on quarterly earnings reports from Pfizer and McDonald's.
Read more »